Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $308.19 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Zimmer Biomet Holdings, Inc. | $96.21 | 3 | $0 (2024) |
| Abbott Laboratories | $73.91 | 2 | $0 (2024) |
| Medtronic Vascular, Inc. | $70.10 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $46.59 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $21.38 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $146.10 | 4 | Abbott Laboratories ($73.91) |
| 2023 | $24.02 | 1 | Zimmer Biomet Holdings, Inc. ($24.02) |
| 2019 | $21.38 | 1 | Novartis Pharmaceuticals Corporation ($21.38) |
| 2018 | $46.59 | 1 | AstraZeneca Pharmaceuticals LP ($46.59) |
| 2017 | $70.10 | 1 | Medtronic Vascular, Inc. ($70.10) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Vascular | ||||||
| 08/05/2024 | Zimmer Biomet Holdings, Inc. | STERNALOCK BLU SYSTEM (Device) | Food and Beverage | In-kind items and services | $41.33 | General |
| Category: CMF & Thoracic | ||||||
| 02/08/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $59.66 | General |
| Category: Vascular | ||||||
| 02/05/2024 | Zimmer Biomet Holdings, Inc. | STERNALOCK BLU SYSTEM (Device) | Food and Beverage | In-kind items and services | $30.86 | General |
| Category: CMF & Thoracic | ||||||
| 10/04/2023 | Zimmer Biomet Holdings, Inc. | STERNALOCK BLU SYSTEM (Device) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: CMF & Thoracic | ||||||
| 04/23/2019 | Novartis Pharmaceuticals Corporation | DUREZOL (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/06/2018 | AstraZeneca Pharmaceuticals LP | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $46.59 | General |
| Category: Neuroscience | ||||||
| 03/21/2017 | Medtronic Vascular, Inc. | Affinity Fusion (Device) | Food and Beverage | In-kind items and services | $70.10 | General |
| Category: Cardiopulmonary | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 195 | 204 | $226,526 | $67,951 |
| 2022 | 6 | 148 | 148 | $183,695 | $53,072 |
| 2021 | 5 | 129 | 133 | $152,302 | $44,088 |
| 2020 | 4 | 109 | 116 | $142,635 | $42,432 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 33533 | Coronary artery bypass using artery graft, 1 graft | Facility | 2023 | 37 | 37 | $161,358 | $43,614 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $18,103 | $8,703 | 48.1% |
| 33519 | Coronary artery bypass using vein or artery graft, 3 grafts | Facility | 2023 | 15 | 15 | $19,749 | $5,764 | 29.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 32 | $10,500 | $4,113 | 39.2% |
| 33518 | Coronary artery bypass using vein or artery graft, 2 grafts | Facility | 2023 | 13 | 13 | $12,123 | $3,487 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 17 | $3,457 | $1,548 | 44.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 19 | $1,236 | $721.43 | 58.4% |
| 33533 | Coronary artery bypass using artery graft, 1 graft | Facility | 2022 | 29 | 29 | $139,594 | $35,757 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $17,816 | $8,316 | 46.7% |
| 33521 | Coronary artery bypass using vein or artery graft, 4 grafts | Facility | 2022 | 11 | 11 | $18,590 | $5,490 | 29.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $4,224 | $1,969 | 46.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 17 | $2,967 | $1,391 | 46.9% |
| 33508 | Harvest of vein using an endoscope | Facility | 2022 | 12 | 12 | $504.00 | $148.68 | 29.5% |
| 33533 | Heart artery bypass, single graft | Facility | 2021 | 25 | 25 | $125,650 | $31,250 | 24.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 58 | 58 | $15,312 | $7,003 | 45.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $4,770 | $2,326 | 48.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 22 | $3,762 | $2,142 | 56.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 13 | $2,808 | $1,368 | 48.7% |
| 33533 | Heart artery bypass to repair one artery | Facility | 2020 | 25 | 25 | $122,058 | $32,819 | 26.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 40 | 40 | $10,560 | $4,741 | 44.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 23 | 24 | $5,400 | $2,614 | 48.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 27 | $4,617 | $2,257 | 48.9% |
About Dr. David Goff, MD
Dr. David Goff, MD is a Cardiovascular Disease healthcare provider based in Ogden, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255449351.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Goff, MD has received a total of $308.19 in payments from pharmaceutical and medical device companies, with $146.10 received in 2024. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($308.19).
As a Medicare-enrolled provider, Goff has provided services to 581 Medicare beneficiaries, totaling 601 services with total Medicare billing of $207,543. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Vascular Surgery, Thoracic Surgery (Cardiothoracic Vascular Surgery)
- Location Ogden, UT
- Active Since 08/28/2006
- Last Updated 05/03/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1255449351
Products in Payments
- STERNALOCK BLU SYSTEM (Device) $96.21
- MITRACLIP (Device) $73.91
- Affinity Fusion (Device) $70.10
- MOVANTIK (Drug) $46.59
- DUREZOL (Drug) $21.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Ogden
Dr. Peter Forstall, M.d, M.D
Cardiovascular Disease — Payments: $10,476
Michael Crawford, Md, MD
Cardiovascular Disease — Payments: $7,588
Charlie Brunson, Md, MD
Cardiovascular Disease — Payments: $6,216
Dr. Sergio Collado, M.d, M.D
Cardiovascular Disease — Payments: $3,145
Dr. Saima Husain, M.d, M.D
Cardiovascular Disease — Payments: $2,973
Dr. Michael Buch, Md, MD
Cardiovascular Disease — Payments: $2,466